Cargando…
The immunomodulatory effects of probiotics on respiratory viral infections: A hint for COVID-19 treatment?
Respiratory virus infections are among the most prevalent diseases in humans and contribute to morbidity and mortality in all age groups. Moreover, since they can evolve fast and cross the species barrier, some of these viruses, such as influenza A and coronaviruses, have sometimes caused epidemics...
Autores principales: | Mahooti, Mehran, Miri, Seyed Mohammad, Abdolalipour, Elahe, Ghaemi, Amir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7431320/ https://www.ncbi.nlm.nih.gov/pubmed/32818576 http://dx.doi.org/10.1016/j.micpath.2020.104452 |
Ejemplares similares
-
Role of γδ T cells in controlling viral infections with a focus on influenza virus: implications for designing novel therapeutic approaches
por: Sabbaghi, Ailar, et al.
Publicado: (2020) -
Role of myeloid-derived suppressor cells in viral respiratory infections; Hints for discovering therapeutic targets for COVID-19
por: Koushki, Khadijeh, et al.
Publicado: (2021) -
Correction to: Synergy between hemagglutinin 2 (HA2) subunit of influenza fusogenic membrane glycoprotein and oncolytic Newcastle disease virus suppressed tumor growth and further enhanced by Immune checkpoint PD-1 blockade
por: Miri, Seyed Mohammad, et al.
Publicado: (2020) -
Synergy between hemagglutinin 2 (HA2) subunit of influenza fusogenic membrane glycoprotein and oncolytic Newcastle disease virus suppressed tumor growth and further enhanced by Immune checkpoint PD-1 blockade
por: Miri, Seyed Mohammad, et al.
Publicado: (2020) -
Recombinant COVID-19 vaccine based on recombinant RBD/Nucleoprotein and saponin adjuvant induces long-lasting neutralizing antibodies and cellular immunity
por: Ghaemi, Amir, et al.
Publicado: (2022)